Inflammatory potential of diet and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 17 10 2018
accepted: 11 03 2019
pubmed: 25 3 2019
medline: 7 1 2021
entrez: 24 3 2019
Statut: ppublish

Résumé

Chronic inflammation plays a critical role in lymphomagenesis and several dietary factors seem to be involved its regulation. The aim of the current study was to assess the association between the inflammatory potential of the diet and the risk of lymphoma and its subtypes in the European Investigation into Cancer and Nutrition (EPIC) study. The analysis included 476,160 subjects with an average follow-up of 13.9 years, during which 3,136 lymphomas (135 Hodgkin lymphoma (HL), 2606 non-Hodgkin lymphoma (NHL) and 395 NOS) were identified. The dietary inflammatory potential was assessed by means of an inflammatory score of the diet (ISD), calculated using 28 dietary components and their corresponding inflammatory weights. The association between the ISD and lymphoma risk was estimated by hazard ratios (HR) and 95% confidence intervals (CI) calculated by multivariable Cox regression models adjusted for potential confounders. The ISD was not associated with overall lymphoma risk. Among lymphoma subtypes, a positive association between the ISD and mature B-cell NHL (HR for a 1-SD increase: 1.07 (95% CI 1.01; 1.14), p trend = 0.03) was observed. No statistically significant association was found among other subtypes. However, albeit with smaller number of cases, a suggestive association was observed for HL (HR for a 1-SD increase = 1.22 (95% CI 0.94; 1.57), p trend 0.13). Our findings suggested that a high ISD score, reflecting a pro-inflammatory diet, was modestly positively associated with the risk of B-cell lymphoma subtypes. Further large prospective studies on low-grade inflammation induced by diet are warranted to confirm these findings.

Identifiants

pubmed: 30903361
doi: 10.1007/s00394-019-01947-0
pii: 10.1007/s00394-019-01947-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

813-823

Subventions

Organisme : Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), CERCA Programme / Generalitat de Catalunya for Institutional support
ID : 2017SGR1085
Organisme : Cancer Research UK
ID : 14136 (to EPIC-Norfolk), C570/A16491 and C8221/A19170 (to EPIC-Oxford)
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1000143 (to EPIC-Norfolk), MR/M012190/1 (to EPIC-Oxford, UK)
Pays : United Kingdom
Organisme : Spanish Ministry of Economy and Competitiveness - Carlos III Institute of Health cofunded by FEDER funds/European Regional Development Fund (ERDF)-a way to build Europe
ID : PI13/00061 (to Granada), PI13/01162 (to EPIC-Murcia, Regional Governments of Andalucıa, Asturias, Basque Country, Murcia and Navarra), PI17/01280 and PI14/01219 (to Barcelona), Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP, Spain)
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Références

Int J Cancer. 2018 Aug 1;143(3):486-495
pubmed: 29460427
Blood. 2009 Sep 24;114(13):2730-2
pubmed: 19638620
CA Cancer J Clin. 2006 Mar-Apr;56(2):69-83
pubmed: 16514135
Eur J Nutr. 2018 Apr;57(3):1207-1213
pubmed: 28251340
Br J Nutr. 2015 Oct 14;114(7):999-1012
pubmed: 26228057
Haematologica. 2018 Oct;103(10):1679-1687
pubmed: 29930163
Cancer Causes Control. 2017 Jul;28(7):791-799
pubmed: 28503716
Cancer Res. 2011 Jul 15;71(14):4898-907
pubmed: 21632552
Am J Clin Nutr. 2018 Apr 1;107(4):607-616
pubmed: 29635497
Public Health Nutr. 2002 Dec;5(6B):1125-45
pubmed: 12639223
Eur J Clin Nutr. 2002 Nov;56(11):1130-6
pubmed: 12428180
Cancer Causes Control. 2010 Aug;21(8):1323-33
pubmed: 20373009
Ann Oncol. 2012 Aug;23(8):2128-2137
pubmed: 22241896
Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):337-47
pubmed: 23300021
Cancer Res. 2012 Sep 15;72(18):4733-43
pubmed: 22846913
Nutrition. 2018 Sep;53:43-48
pubmed: 29655776
Br J Haematol. 2014 Feb;164(4):536-45
pubmed: 24245986
Eur J Clin Nutr. 2006 Jan;60(1):41-7
pubmed: 16132058
Int J Epidemiol. 1997;26 Suppl 1:S1-5
pubmed: 9126528
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44
pubmed: 25174034
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2383-92
pubmed: 25155761
J Intern Med. 2017 Nov;282(5):360-370
pubmed: 28875507
Curr Opin Lipidol. 2002 Feb;13(1):3-9
pubmed: 11790957
Exp Hematol. 2006 Apr;34(4):399-406
pubmed: 16569586
Int J Cancer. 2017 Aug 1;141(3):471-479
pubmed: 28340515
Br J Nutr. 2011 Dec;106 Suppl 3:S5-78
pubmed: 22133051
Am J Clin Nutr. 2004 Oct;80(4):1029-35
pubmed: 15447916
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1577-84
pubmed: 20501772
Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1064-77
pubmed: 21493873
Int J Cancer. 2016 Sep 15;139(6):1251-60
pubmed: 27149545
J Intern Med. 2008 Dec;264(6):514-27
pubmed: 19017176
Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1925-7
pubmed: 21784955
Am J Clin Nutr. 2013 Dec;98(6):1533-42
pubmed: 24153342
Br J Nutr. 2015 Jan 28;113(2):278-83
pubmed: 25400225
Int J Epidemiol. 1997;26 Suppl 1:S6-14
pubmed: 9126529
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2069-77
pubmed: 17119030
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Public Health Nutr. 2014 Aug;17(8):1689-96
pubmed: 23941862
Blood. 2013 Aug 8;122(6):951-7
pubmed: 23814017
Blood. 2010 Nov 18;116(20):e90-8
pubmed: 20699439
Am J Epidemiol. 2004 Oct 15;160(8):814-22
pubmed: 15466504
Br J Cancer. 2015 Sep 29;113(7):1099-103
pubmed: 26335605

Auteurs

Marta Solans (M)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain.
Epidemiology Unit and Girona Cancer Registry, Catalan Institute of Oncology, Girona, Spain.

Yolanda Benavente (Y)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Unit of Molecular and Genetic Epidemiology in Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology (ICO-IDIBELL), Av. Gran Via de l'Hospitalet 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.

Marc Saez (M)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.

Paula Jakszyn (P)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.

Sabine Naudin (S)

Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Fatemeh Saberi Hosnijeh (FS)

Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Immunology Department, Erasmus University Medical Center, Rotterdam, The Netherlands.

Marc Gunter (M)

Nutritional Epidemiology Group (NEP), International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Inge Huybrechts (I)

Nutritional Epidemiology Group (NEP), International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Pietro Ferrari (P)

Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Caroline Besson (C)

Department of Hematology and Oncology, Hospital of Versailles, Le Chesnay, France.
CESP, Fac. de médecine-Univ. Paris-Sud, Fac. de médecine-UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Yahya Mahamat-Saleh (Y)

CESP, Fac. de médecine-Univ. Paris-Sud, Fac. de médecine-UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Marie-Christine Boutron-Ruault (MC)

CESP, Fac. de médecine-Univ. Paris-Sud, Fac. de médecine-UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Tilman Kühn (T)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition (DIfE) Postdam-Rehbrücke, Nuthetal, Germany.

Cristina Lasheras (C)

Department of Functional Biology, Oviedo University, Oviedo, Spain.

Maria-Jose Sánchez (MJ)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs. GRANADA, Granada, Spain.

Pilar Amiano (P)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Public Health Division of Gipuzkoa, Regional Government of the Basque Country, Donostia, Spain.

María Dolores Chirlaque (MD)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.

Eva Ardanaz (E)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

Julie A Schmidt (JA)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Paolo Vineis (P)

Department of Epidemiology and Biostatistics, MRC-HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.

Elio Riboli (E)

School of Public Health, Imperial College London, London, UK.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Anna Karakatsani (A)

Hellenic Health Foundation, Athens, Greece.
Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece.

Elisavet Valanou (E)

Hellenic Health Foundation, Athens, Greece.

Giovanna Masala (G)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, 50141, Florence, Italy.

Claudia Agnoli (C)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, "Civic-M. P. Arezzo" Hospital, ASP, Ragusa, Ragusa, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.

Amalia Mattiello (A)

Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.

Guri Skeie (G)

Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.

Elisabete Weiderpass (E)

Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Department of Research, Cancer Registry of Norway-Institute of Population-Based Cancer Research, Oslo, Norway.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Genetic Epidemiology Group, Folkhälsan Research Center, Faculty of Medicine, Helsinki University, Helsinki, Finland.

Mats Jerkeman (M)

Department of Oncology, Skåne University Hospital, Lund, Sweden.

Joana Alves Dias (JA)

Department of Clinical Sciences, Research Group in Nutritional Epidemiology, Lund University, Malmö, Sweden.

Florentin Späth (F)

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.

Lena Maria Nilsson (LM)

Public Health and Clinical Medicine, Nutritional Research and Arctic Research Centre, Umeå University, Umeå, Sweden.

Christina C Dahm (CC)

Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.

Kim Overvad (K)

Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.

Kristina Elin Nielsen Petersen (KEN)

Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.

Anne Tjønneland (A)

Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Silvia de Sanjose (S)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Unit of Molecular and Genetic Epidemiology in Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology (ICO-IDIBELL), Av. Gran Via de l'Hospitalet 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
PATH, Reproductive Health, Seattle, USA.

Roel Vermeulen (R)

Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.

Alexandra Nieters (A)

Center for Chronic Immunodeficiency (CCI), Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.

Delphine Casabonne (D)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. dcasabonne@iconcologia.net.
Unit of Molecular and Genetic Epidemiology in Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology (ICO-IDIBELL), Av. Gran Via de l'Hospitalet 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain. dcasabonne@iconcologia.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH